Lynette M. Sholl
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 118
- Lung Cancer Diagnosis and Treatment 26
- Oncology 135
- Cancer Immunotherapy and Biomarkers 38
- Lung Cancer Research Studies 33
- Colorectal Cancer Treatments and Studies 24
- Co-authors
- Jason L. Hornick (26 shared papers)Pasi A. Jänne (51 shared papers)Mizuki Nishino (42 shared papers)Mark M. Awad (58 shared papers)Geoffrey R. Oxnard (26 shared papers)Ming‐Sound Tsao (8 shared papers)Suzanne E. Dahlberg (11 shared papers)Mary Beth Beasley (13 shared papers)
- Journals
- Journal of Clinical Oncology (39 papers)Journal of Thoracic Oncology (32 papers)Modern Pathology (30 papers)The American Journal of Surgical Pathology (20 papers)Histopathology (16 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Lynette M. Sholl
289 papers receiving 14.4k citations
Lynette M. Sholl's Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 6.9k
- Pulmonary and Respiratory Medicine 6.8k
- Cancer Research 3.1k
- Pathology and Forensic Medicine 1.9k
- Obstetrics and Gynecology 610
Countries citing papers authored by Lynette M. Sholl
This map shows the geographic impact of Lynette M. Sholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette M. Sholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette M. Sholl more than expected).
Fields of papers citing papers by Lynette M. Sholl
This network shows the impact of papers produced by Lynette M. Sholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette M. Sholl. The network helps show where Lynette M. Sholl may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynette M. Sholl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 310 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1 as a biomarker of response to immune-checkpoint inhibitors Hit paper breakdown → | 2021 | 980 |
| 2 | The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 Hit paper breakdown → | 2021 | 752 |
| 3 | Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1 Hit paper breakdown → | 2015 | 516 |
| 4 | Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib Hit paper breakdown → | 2018 | 513 |
| 5 | MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression Hit paper breakdown → | 2016 | 493 |
| 6 | PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course Hit paper breakdown → | 2016 | 361 |
| 7 | 2018 | 348 | |
| 8 | 2017 | 318 | |
| 9 | 2015 | 303 | |
| 10 | 2014 | 292 | |
| 11 | 2012 | 276 | |
| 12 | 2013 | 274 | |
| 13 | 2017 | 266 | |
| 14 | 2016 | 224 | |
| 15 | 2015 | 211 | |
| 16 | 2020 | 201 | |
| 17 | 2019 | 201 | |
| 18 | 2019 | 174 | |
| 19 | 2014 | 163 | |
| 20 | 2010 | 139 |
About Lynette M. Sholl
Lynette M. Sholl is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 310 papers that have together received 14.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (118 papers), Cancer Genomics and Diagnostics (102 papers), Cancer Immunotherapy and Biomarkers (38 papers), Lung Cancer Research Studies (33 papers), Lung Cancer Diagnosis and Treatment (26 papers), Genetic factors in colorectal cancer (24 papers), Colorectal Cancer Treatments and Studies (24 papers) and Neuroendocrine Tumor Research Advances (15 papers). The work is most often cited by research in Oncology (6.9k citations), Pulmonary and Respiratory Medicine (6.8k citations), Cancer Research (3.1k citations), Pathology and Forensic Medicine (1.9k citations) and Obstetrics and Gynecology (610 citations). Lynette M. Sholl has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jason L. Hornick, Pasi A. Jänne, Mizuki Nishino, Mark M. Awad, Geoffrey R. Oxnard, Ming‐Sound Tsao, Suzanne E. Dahlberg, Mary Beth Beasley, Keith M. Kerr and Scott J. Rodig. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Modern Pathology, The American Journal of Surgical Pathology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.